The text has been copied to the clipboard
Journal article

Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.

  • Costamagna A Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Rossi Sebastiano M Institut für Pharmacologie, Universität Bern, Inelspital INO-F, CH-3010, Bern, Switzerland.
  • Natalini D Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Simoni M Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Valabrega G Candiolo Cancer Institute, FPO - IRCCS -, Candiolo, (TO), 10060, Italy.
  • Defilippi P Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Visentin S Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Ermondi G Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Turco E Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Caron G Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy.
  • Cabodi S Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126, Torino, Italy. sara.cabodi@unito.it.
Show more…
  • 2019-11-24
Published in:
  • Scientific reports. - 2019
English An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/185139
Export to…

Statistics

Document views: 73 File downloads:
  • Full-text: 0